Conduct of a hands-on training on the use of in silico tools in chemical hazard assessment
In collaboration with Center for Alternatives to Animal Testing (CAAT), ToxMinds conducted a 2-day hands-on training on the use of in silico tools in wider context of chemical hazard assessment.
Read More
Science advocacy to prevent onerous classification of a chemical substance for acute inhalation toxicity
ToxMinds developed the technical argumentation and science advocacy strategy to prevent an onerous, scientifically unjustified classification & labeling (CLH) proposal
Read More
Establishing health-based exposure limits (PDE) for pharmaceutical actives
ToxMinds established, in line with EMA guidance, permitted daily exposures for more than 30 active pharmaceutical ingredients to allow managing any API residues in case of shared facility manufacturing arrangement.
Read More
Consortium management and technical support to European REACH and Biocides consortia
ToxMinds is the consortium management organisation and technical lead consultancy for 3 REACH and 1 Biocides consortia
Read More
REACH strategy and registration support to chemical manufacturers
With more than 250 REACH registrations over the last 8 years, ToxMinds is trusted by its clients in the REACH registration process.
Read More
Inhalation exposure and risk assessment associated with the release of VOC, SVOC and particulates from scented candles
ToxMinds assessed consumer exposures and risks associated with the release of volatile organic compounds, including benzene, formaldehyde and naphthalene from scented candles.
Read More
Identification of hazards associated with non-intentionally added substances in a food contact polymer
ToxMinds was tasked by a petrochemical company to assess the toxicological hazard of and derive MRLs for non-intentionally added substances in a food contact polymer.
Read More
Development of permissible daily exposure levels of impurities present in pharmaceutical products
ToxMinds is a key resource to a major multinational biopharmaceutical company on the safety assessment of extractables & leachables and manufacturing impurities ending up in the medicinal product.
Read More
Human health risk assessment of a biocidal product line for due diligence purposes
ToxMinds supported the acquisition of a biocidal product line by a multinational consumer product company by demonstrating the safety of the products for children and adults under in-use conditions.
Read More